FSAGX
Price
$24.74
Change
-$0.57 (-2.25%)
Updated
Dec 20 closing price
RYMPX
Price
$33.87
Change
+$0.45 (+1.35%)
Updated
Dec 20 closing price
Ad is loading...

FSAGX vs RYMPX

Header iconFSAGX vs RYMPX Comparison
Open Charts FSAGX vs RYMPXBanner chart's image
Fidelity Select Gold
Price$24.74
Change-$0.57 (-2.25%)
VolumeN/A
CapitalizationN/A
Rydex Precious Metals H
Price$33.87
Change+$0.45 (+1.35%)
VolumeN/A
CapitalizationN/A
FSAGX vs RYMPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSAGX vs. RYMPX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSAGX is a Hold and RYMPX is a Hold.

FUNDAMENTALS
Fundamentals
FSAGX has more cash in the bank: 1.44B vs. RYMPX (79.9M). RYMPX pays higher dividends than FSAGX: RYMPX (3.86) vs FSAGX (0.97). FSAGX was incepted earlier than RYMPX: FSAGX (39 years) vs RYMPX (21 years). RYMPX is a more actively managed with annual turnover of: 424.00 vs. FSAGX (46.00). FSAGX has a lower initial minimum investment than RYMPX: FSAGX (0) vs RYMPX (2500). FSAGX annual gain was more profitable for investors over the last year : 14.68 vs. RYMPX (10.04). RYMPX return over 5 years is better than : 37.94 vs. FSAGX (23.46).
FSAGXRYMPXFSAGX / RYMPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence39 years21 years-
Gain YTD15.71811.414138%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.44B79.9M1,800%
Annual Yield % from dividends0.973.8625%
Returns for 1 year14.6810.04146%
Returns for 3 years3.686.8054%
Returns for 5 years23.4637.9462%
Returns for 10 years79.18104.8076%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BEPC28.300.62
+2.24%
Brookfield Renewable Corp
BKR40.320.52
+1.31%
Baker Hughes Company
NGD2.510.03
+1.21%
New Gold
NVX1.650.01
+0.61%
NOVONIX Limited
IRD0.98-0.01
-0.87%
Opus Genetics Inc